These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 104814)

  • 21. Autoantibody to the alternative pathway C3/C5 convertase and its anti-idiotypic response. A study in affinity.
    Spitzer RE; Stitzel AE; Tsokos GC
    J Immunol; 1992 Jan; 148(1):137-41. PubMed ID: 1727863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes gestationis associated with the C3 nephritic factor.
    Grimwood R; Arroyave CM; Weston WL; Aeling JL
    Arch Dermatol; 1980 Sep; 116(9):1045-7. PubMed ID: 6998378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
    Arroyave CM; Wilson MR; Tan EM
    J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of carbohydrate in the structure and function of nephritic factor.
    Scott DM; Amos N; Bartolotti SR
    Clin Exp Immunol; 1981 Oct; 46(1):120-9. PubMed ID: 6802534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that an autoantibody of IgG3 subclass against C3b discloses a C3 Nef activity in a pateint with partial lipodystrophy and glomerulonephritis.
    Fontaine M; Daveau M; Lebreton JP; Dumouchel L; Vannier JP; Godin M
    Ann Immunol (Paris); 1980; 131C(1):39-53. PubMed ID: 6901590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of C3 nephritic factor on the complement system--with special reference to stabilizing effect on C3 convertase (C3bBb) activity (author's transl)].
    Nakanishi I
    Nihon Jinzo Gakkai Shi; 1981 Jun; 23(6):719-32. PubMed ID: 6914399
    [No Abstract]   [Full Text] [Related]  

  • 30. IgG subclass studies of C3 nephritic factor.
    Davis AE; Gelfand EW; Schur PH; Rosen FS; Alper CA
    Clin Immunol Immunopathol; 1978 Sep; 11(1):98-101. PubMed ID: 699392
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence that production of autoantibody to the alternative pathway C3 convertase is a normal physiologic event.
    Spitzer RE; Stitzel AE; Tsokos GC
    J Pediatr; 1990 May; 116(5):S103-8. PubMed ID: 2329411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Feb; 116(2):568-70. PubMed ID: 1249423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic urticaria and acquired complement deficiency due to a nephritic factor (C3NeF)].
    Borradori L; Rybojad M; Weiss L; Späth P; Puissant A; Morel P
    Schweiz Med Wochenschr; 1990 Aug; 120(34):1236-41. PubMed ID: 2218445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Production of C3 nephritic factor by cultured lymphocytes derived from glomerulonephritic patients].
    Yamada A; Ohi H; Hatano M
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):373-8. PubMed ID: 2376910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide sequence of a human autoantibody to the alternative pathway C3/C5 convertase (C3NeF).
    Victor KD; Pascual V; Stitzel AE; Tsokos GC; Capra JD; Spitzer RE
    Hybridoma; 1993 Jun; 12(3):231-7. PubMed ID: 8395463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C3 nephritic factor and mesangiocapillary glomerulonephritis.
    Williams DG
    Pediatr Nephrol; 1997 Feb; 11(1):96-8. PubMed ID: 9035182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement activation by circulating serum factors in human glomerulonephritis.
    Meri S
    Clin Exp Immunol; 1985 Feb; 59(2):276-84. PubMed ID: 3919977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
    Watanabe S; Ohi H; Seki M; Fujita T; Hatano M
    Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
    [No Abstract]   [Full Text] [Related]  

  • 40. A C3 convertase assay for nephritic factor functional activity.
    Jelezarova E; Schlumberger M; Sadallah S; Späth PJ; Schifferli JA; Lutz HU
    J Immunol Methods; 2001 May; 251(1-2):45-52. PubMed ID: 11292480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.